Oricell Therapeutics: Series C1
Develops next-generation cell therapies for solid tumors and hematologic malignancies
Oricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
Company profile and funding historyDevelops next-generation cell therapies for solid tumors and hematologic malignancies
Develops next-generation cell therapies for oncology and immunology
Company profile and funding history